Drugs in MeSH Category GABA-B Receptor Agonists
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | LYVISPAH | baclofen | GRANULES;ORAL | 215422-002 | Nov 22, 2021 | RX | Yes | No | 11,850,225 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Unichem | BACLOFEN | baclofen | TABLET;ORAL | 212067-002 | Jul 9, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Amneal | LYVISPAH | baclofen | GRANULES;ORAL | 215422-001 | Nov 22, 2021 | RX | Yes | No | 11,931,328 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Andas 5 Holding | BACLOFEN | baclofen | TABLET;ORAL | 212378-002 | Oct 9, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Amneal | LYVISPAH | baclofen | GRANULES;ORAL | 215422-001 | Nov 22, 2021 | RX | Yes | No | 11,654,124 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
Piramal Critical | GABLOFEN | baclofen | INJECTABLE;INTRATHECAL | 022462-002 | Nov 19, 2010 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Amneal | LYVISPAH | baclofen | GRANULES;ORAL | 215422-002 | Nov 22, 2021 | RX | Yes | No | 10,792,262 | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |